← Back to Search

Standardized Test Questions First Group for Stress (MACEStress Trial)

N/A
Waitlist Available
Led By Martin H Teicher, MD,PhD
Research Sponsored by Mclean Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy volunteers ages 18-65, living full-time in the U.S at the time of participation in the study.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 90 mins
Awards & highlights

MACEStress Trial Summary

Childhood adversity in the form of maltreatment and household dysfunction is the most important risk factor for psychopathology as well as a major risk factor for a host of medical disorders. It has been estimated that adverse childhood experiences account for 45%, 50%, 64% and 67% of the population attributable risk for childhood onset psychiatric disorders, alcoholism, depression, substance abuse and suicide attempts. There is also increasing evidence that maltreated and non-maltreated individuals with the same primary psychiatric diagnosis are clinically and neurobiologically distinct and respond differently to treatment. The investigators and others have proposed that assessment of exposure to maltreatment is imperative for prevention, targeted treatment and research. A potential barrier to the widespread collection of data regarding early life stress and childhood maltreatment is the concern that asking such probing questions, particularly on an online questionnaire, may provoke untoward reactions and create clinical problems. Therefore, the investigators have designed this observational study to test our hypothesis that answering questions about type and timing of childhood maltreatment are no more stressful than answering standardized mathematical and verbal questions, of the type asked on the Scholastic Aptitude Test (SAT). The study will include representative national samples (by age, sex, and ethnicity) from the United States (total N=500, Ages 18-65) and will be conducted online via Prolific™, which maintains a pool of research participants. Participants will be assigned randomly to one of two test sequences. In sequence 1, the Maltreatment and Abuse Chronology of Exposure (MACE) scale will be presented toward the beginning of the session and the Math/Verbal Test toward the end. In sequence 2, the order will be reversed. The impact of completing the MACE and standardized IQ questions will be assessed before and after each module, using the abbreviated form of the Profile of Mood States (POMS).

Eligible Conditions
  • Stress

MACEStress Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MACEStress Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 90 mins
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 90 mins for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Profile of Mood States (POMS)
Total Mood Disturbance (TMD)

MACEStress Trial Design

2Treatment groups
Experimental Treatment
Group I: Standardized Test Questions First GroupExperimental Treatment4 Interventions
This group (N=250) will be presented with the standardized test questions (Math/Verbal) toward the beginning of the session and the Maltreatment and Abuse Chronology of Exposure (MACE) scale toward the end.
Group II: MACE First GroupExperimental Treatment4 Interventions
This group (N=250) will be presented with the Maltreatment and Abuse Chronology of Exposure (MACE) scale toward the beginning of the session and the Math/Verbal Test toward the end.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standardized Maths and Verbal Questions such as the ones used in SATs
2022
N/A
~500
Maltreatment and Abuse Chronology of Exposure Scale as a stress challenge
2022
N/A
~500
International Personality Item Pool (IPIP-NEO)
2022
N/A
~500
Chronology of Perceived Discrimination Scale (CPDS)
2022
N/A
~500

Find a Location

Who is running the clinical trial?

Mclean HospitalLead Sponsor
212 Previous Clinical Trials
21,094 Total Patients Enrolled
Martin H Teicher, MD,PhDPrincipal InvestigatorMclean Hospital
1 Previous Clinical Trials
26 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~200 spots leftby Apr 2025